Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenues:        
License and collaborative fees $ 10,775 $ 275 $ 10,925 $ 2,766
Contract and other 115 168 225 1,639
Total revenues 10,890 443 11,150 4,405
Operating expenses:        
Research and development 2,916 13,703 6,908 27,313
General and administrative 5,203 4,779 10,370 9,084
Restructuring 1,460 (21) 3,480 15
Total operating expenses 9,579 18,461 20,758 36,412
Income (loss) from operations 1,311 (18,018) (9,608) (32,007)
Other income (expense):        
Interest expense (297) (1,007) (906) (2,009)
Other income (expense), net (729) 602 600 296
Revaluation of contingent warrant liabilities   3,263   10,195
Loss on extinguishment of debt     (515)  
Net income (loss) 285 (15,160) (10,429) (23,525)
Basic and diluted net income (loss) available to common stockholders $ 172 $ (15,160) $ (16,032) $ (23,525)
Basic net income (loss) per share available to common stockholders $ 0.02 $ (2.52) $ (2.21) $ (3.92)
Diluted net income (loss) per share available to common stockholders $ 0.02 $ (2.52) $ (2.21) $ (3.92)
Weighted average shares used in computing basic net income (loss) per share available to common stockholders 7,588 6,022 7,240 6,000
Weighted average shares used in computing diluted net income (loss) per share available to common stockholders 7,643 6,022 7,240 6,000
Other comprehensive income (loss):        
Net income (loss) $ 285 $ (15,160) $ (10,429) $ (23,525)
Net unrealized loss on marketable securities   (12)   (54)
Total comprehensive income (loss) $ 285 $ (15,172) $ (10,429) $ (23,579)